written on 14.05.2014

Targeted Therapy in NSCLC Part II: EGF / EGFR


In the second in this series on targeted therapy in non small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR) can be considered to have been the first ‘target’ recognized for therapy. Thus EGFR plays a key role in the beginning of the era of personalized medicine in NSCLC. See Part I of the […]